Table 3.
Evaluation of HPV and p53 expression in PVL
Case | HPV+/total cases | HPV types | Detection technique | p53 | Detection technique | Reference |
---|---|---|---|---|---|---|
1 | 8/9 |
HPV 16 (n = 7) HPV 18 (n = 1) |
PCR | NP | NP | Palefsky et al. [3] |
2 | 2/10 |
HPV 16 (n = 1) HPV 18 (n = 1) |
PCR | 8/10 | IHC, PCR | Gopalakrishnan et al. [14] |
3 | 0/10 | NA | PCR | 4/10 | IHC | Fettig et al. [9] |
4 | 50/50 |
HPV 11 HPV 16 HPV18 |
PCR | NP | NP | Femiano et al. [29] |
5 | 14/58 |
HPV 16 (n = 4) HPV 18 (n = 10) |
PCR | NP | NP | Campisi et al. [8] |
6 | 0/13 | HPV-6, 11, 16,18, 26, 31, 33, 35, 40, 45, 51, 52, 56, 59 | PCR | NP | NP | Bagan et al. [6] |
7 | 0/13 tested (n = 20) |
HPV 16 HPV 18 |
ISH | 13/13 tested (n = 20) | IHC | Our study |
HPV human papillomavirus, IHC immunohistochemistry, ISH in-situ hybridization, NA not available, NP not performed, PCR polymerase chain reaction